Sociedad Americana de Hirudoterapia

A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee

Lauche R, Cramer H, Langhorst J, Dobos G (2014) · The Clinical Journal of Pain · n=237

RCT evidence detailTrial reference
Sample size of this trial compared with other Knee Osteoarthritis trialsWang H 2018264Lauche R 2025240Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Sarbaev IS 201996Isik M 201790Khoshnevisan A 202280
This trial (highlighted) by sample size alongside other indexed Knee Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
systematic review and meta-analysis of randomized and nonrandomized controlled clinical trials of medical leech therapy for knee OA
Sample size (n)
237
Intervention
Pooled analysis of 3 RCTs and 1 controlled clinical trial of medicinal leech therapy in knee OA (Michalsen 2003, Andereya 2008, Stange 2011/2012, plus one CCT)
Comparator
Pooled across studies: topical diclofenac, hyaluronic acid, NSAIDs, TENS, or other conventional care
Primary endpoint
Standardized mean difference (SMD) for pain, functional impairment, and joint stiffness at multiple time points
Primary result
Strong evidence for immediate (SMD=-1.05; p<0.01) and short-term pain reduction (SMD=-1.00; p<0.01); immediate improvement in physical function (SMD=-0.72; p<0.01); both immediate (SMD=-0.88; p=0.04) and long-term improvement in joint stiffness (SMD=-0.62; p<0.01); moderate evidence for short-term function (SMD=-0.46) and long-term pain (SMD=-0.45)
Follow-up duration
up to 12 months across pooled trials

Key Findings

  • First systematic review and meta-analysis of leech therapy for knee OA (pre-dating Wang 2018)
  • Pooled n=237 across 3 RCTs and 1 CCT showed strong evidence for pain reduction, functional improvement, and stiffness reduction
  • Standardized mean difference (SMD) for immediate pain reduction was -1.05, a large effect by Cohen's conventional thresholds
  • Three of four included trials had low risk of bias per the authors' assessment
  • No serious adverse events reported in the pooled cohort

Limitations

  • Only 4 included trials at the time of analysis (2012 search) - small evidence base
  • All included trials open-label - sham-controlled trials (Hohmann 2014, ELECT 2025) not yet available
  • Heterogeneous comparators (topical diclofenac, HA, NSAIDs, TENS) reduce interpretability
  • Authors note that further high-quality RCTs are needed for conclusive judgment
  • Geographic bias - most included trials German

Clinical Implications

Lauche 2014 meta-analysis is the foundational quantitative synthesis of the German leech-OA literature and supports the GRADE 'moderate' rating that the ASH editorial board applies to knee OA. The standardized mean difference of -1.05 for immediate pain (large effect) is one of the strongest pooled effects reported for any non-pharmacologic OA intervention. Clinicians citing the leech-knee-OA evidence should cite this meta-analysis alongside the underlying RCTs (Michalsen 2003, Andereya 2008, Stange 2011/2012). The meta-analysis was updated by Wang 2018 with similar conclusions.

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.